1. Home
  2. SXI vs TARS Comparison

SXI vs TARS Comparison

Compare SXI & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXI
  • TARS
  • Stock Information
  • Founded
  • SXI 1955
  • TARS 2016
  • Country
  • SXI United States
  • TARS United States
  • Employees
  • SXI N/A
  • TARS N/A
  • Industry
  • SXI Industrial Machinery/Components
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • SXI Industrials
  • TARS Health Care
  • Exchange
  • SXI Nasdaq
  • TARS Nasdaq
  • Market Cap
  • SXI 2.3B
  • TARS 2.0B
  • IPO Year
  • SXI N/A
  • TARS 2020
  • Fundamental
  • Price
  • SXI $190.26
  • TARS $47.84
  • Analyst Decision
  • SXI Strong Buy
  • TARS Strong Buy
  • Analyst Count
  • SXI 3
  • TARS 6
  • Target Price
  • SXI $231.33
  • TARS $56.00
  • AVG Volume (30 Days)
  • SXI 61.2K
  • TARS 460.8K
  • Earning Date
  • SXI 01-30-2025
  • TARS 02-25-2025
  • Dividend Yield
  • SXI 0.67%
  • TARS N/A
  • EPS Growth
  • SXI N/A
  • TARS N/A
  • EPS
  • SXI 4.56
  • TARS N/A
  • Revenue
  • SXI $717,739,000.00
  • TARS $129,621,000.00
  • Revenue This Year
  • SXI $9.81
  • TARS $921.89
  • Revenue Next Year
  • SXI $13.28
  • TARS $85.83
  • P/E Ratio
  • SXI $41.46
  • TARS N/A
  • Revenue Growth
  • SXI N/A
  • TARS 801.96
  • 52 Week Low
  • SXI $154.45
  • TARS $20.08
  • 52 Week High
  • SXI $212.66
  • TARS $57.28
  • Technical
  • Relative Strength Index (RSI)
  • SXI 44.27
  • TARS 39.21
  • Support Level
  • SXI $185.45
  • TARS $49.86
  • Resistance Level
  • SXI $192.41
  • TARS $53.22
  • Average True Range (ATR)
  • SXI 4.73
  • TARS 2.44
  • MACD
  • SXI -0.41
  • TARS -0.56
  • Stochastic Oscillator
  • SXI 39.00
  • TARS 7.09

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: